Percutaneous biopsies allow for precise diagnosis in soft tissue sarcomas and have a low rate of complications. However, it is unknown whether biopsies performed in a community setting lead to higher rates of wound complications at the time of resection. The goal of this study was to determine whether percutaneous biopsies performed at a sarcoma center have lower rates of wound complications compared with those performed in the community setting. A total of 125 patients with soft tissue sarcomas were treated with neoadjuvant radiation followed by limb-sparing resection. Of these, 92 underwent percutaneous biopsy. Patient, demographic, and treatment variables and postoperative wound complications were reviewed. Predictors of wound complications were evaluated with Fisher's exact test for univariate analysis and with logistic regression for multivariate analysis. The wound complication rate was 27% for open or percutaneous biopsies. When only percutaneous biopsies were assessed, the wound complication rate was 25%. The wound complication rate for percutaneous biopsies was 18% when the biopsy was performed at the authors' sarcoma center and 46% when the biopsy was performed in the community setting (P=.01). The Common Terminology Criteria for Adverse Events grade 4 wound complication rate was 73% in patients who underwent percutaneous biopsy at a community hospital vs 14% in those who underwent percutaneous biopsy at the authors' sarcoma center (P=.005). Multivariate analysis showed that lower-extremity soft tissue sarcomas (P=.03) and biopsies performed in the community setting (P=.01) had an increased rate of postoperative wound complications. Percutaneous biopsies performed at community hospitals had an increased incidence of grade 4 postoperative wound toxicity compared with biopsies done at tertiary centers. These wound results confirmed previous recommendations that biopsy of soft tissue sarcomas should be performed at an experienced sarcoma center. [Orthopedics. 2015; 38(9):e753-e759.] The authors are
S oft tissue sarcomas of the extremity and superficial trunk are rare and are often managed with multimodality therapy. Biopsies of sarcomas can be performed through tissue acquisition, with either an open or a percutaneous approach. However, there has been a transition toward percutaneous biopsies because they lead to accurate diagnosis and low complication rates. [1] [2] [3] [4] [5] [6] Open biopsies performed at referring community institutions have increased rates of postoperative wound complications, increased rates of amputation, and the need for soft tissue coverage. 7, 8 However, few studies have examined the effect of percutaneous biopsy performed in a community setting on soft tissue sarcomas treated with neoadjuvant therapy and resection.
Neoadjuvant radiation therapy, with or without chemotherapy, followed by wide surgical resection is well accepted as a treatment for soft tissue sarcomas. Potential advantages of neoadjuvant radiation therapy include decreased target volume, radiation dose, and tumor seeding during sarcoma resection. Preoperative radiation therapy may facilitate resection with close margins and allow for equivalent or decreased local recurrence rates compared with postoperative radiation. However, despite these advantages, an increased rate of postoperative major wound complications has been well documented compared with adjuvant radiation. [9] [10] [11] [12] Studies showed wound complication rates of 30% to 50% in patients who had preoperative radiation therapy, with or without chemotherapy. Other predictors of wound complications included tumor size, tumor location, and patient age. [12] [13] [14] [15] The primary goal of this study was to determine whether percutaneous biopsies performed in patients with soft tissue sarcomas in the community setting are associated with increasing rates of wound complications in those who underwent preoperative radiation therapy and surgical resection. The secondary goal was to determine whether clinical and pathologic factors can be correlated with postoperative wound complications.
Materials and Methods
This research was reviewed and approved by the institutional review board at the study facility. All investigators completed training in human research and patient privacy.
Patient Characteristics
The authors reviewed the records of 185 patients with primary soft tissue sarcomas of the extremities and body wall who underwent surgical resection at the study institution between 2000 and 2010.
The following patients were excluded: those who had metastatic disease on initial presentation, those younger than 18 years, those with soft tissue sarcoma at locations other than the extremity or body wall, those with recurrent sarcomas on first presentation to the sarcoma center, those with small subcutaneous tumors, and those who did not undergo preoperative radiation.
Patients with histopathologic types including rhabdomyosarcoma, extraosseous primitive neuroectodermal tumor, Kaposi's sarcoma, angiosarcoma, and aggressive fibromatosis were also excluded. Also excluded were patients who did not have complete medical records, including treatment information and a pathology report, and those with follow-up of less than 6 months.
Also excluded were 33 patients who underwent postoperative radiation and 27 who had no radiation therapy. This left 125 patients in the cohort, and of these, 92 (74%) had percutaneous biopsies and were available for analysis.
Staging was conducted according to the 2009 American Joint Committee on Cancer system. 16 Patient demographics, comorbidities, tumor characteristics, details of resection and flap reconstruction, and wound outcomes were recorded for each subject and are shown in Image-guided biopsies were performed under the direction of a fellowship-trained musculoskeletal radiologist with either CT or ultrasound guidance at the discretion of the radiologist. After the area of concern was prepared in a sterile fashion, topical anesthetic was applied to the site. A skin incision was made with a No. 11 blade, and several passes were made with a percutaneous core needle through a coaxial sheath. Cores of tissue were acquired, with a goal of 6 to 8 cores.
Core biopsies were performed in the clinic by musculoskeletal oncologists (D.M.K., D.A.H., J.C.N.). Each patient underwent local preparation with povidone-iodine (Betadine; Purdue, Stamford, Connecticut). Ethyl chloride freezing spray was administered to the area, which was then locally infiltrated with 1% lidocaine without epinephrine. An approximately 5-mm skin incision was made with a No. 11 blade. The core biopsy instrument was introduced, and cores of tissue were obtained. The needle was redirected through the same skin incision into different areas of the tumor to minimize sampling error. An attempt was made to obtain 6 to 8 robust cores of tissue.
All specimens were reviewed by experienced musculoskeletal pathologists with standard staining techniques, fluorescence in situ hybridization, molecular genetic testing, and chromosomal and other advanced analysis techniques when appropriate.
Radiation Therapy and Chemotherapy
Patients received a median dose of 50 Gy at 2 Gy per fraction with 3-dimensional conformal radiation therapy or intensity-modulated radiation therapy. Patients who received chemotherapy were typically younger than 70 years and had large, high-grade lesions. Chemotherapy was delivered before radiation therapy in a sequential manner, with doxorubicin (Adriamycin; Pharmacia, Milan, Italy) and ifosfamide given for 3 cycles. If tumors progressed through chemotherapy, 
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Surgery
Limb-sparing resection was performed in all patients 4 to 6 weeks after the completion of radiation therapy. Surgery was performed grossly through normal tissue planes, with sacrifice of tumor-involved arteries or veins. Neurovascular structures were preserved when possible. The goal of surgery was to achieve negative margins. When the percutaneous biopsy site could be identified, it was excised.
At the discretion of the musculoskeletal oncologist, in cases with difficult wound closures, reconstructive plastic surgeons (D.M.K., D.A.H., J.C.N.) performed complex primary closures, splitthickness skin grafts, rotational muscle flaps, and free tissue transfers.
Outcomes
Postoperative wound complications were defined according to the Canadian Multicenter Trial 12 and were recorded if they occurred within 6 months after limb salvage surgery ( Table 2) . Reoperation, prolonged wound care, and the need for antibiotics after resection were considered wound complications. These complications were also graded according to the Common Terminology Criteria for Adverse Events (CTCAE), version 4.0 (Table 3) . 17 Clinical, pathologic, and treatment characteristics of wound complications were also assessed.
Statistical Analysis
Descriptive analysis was used to summarize the characteristics shown in Table  1 .
results
The current study assessed whether percutaneous biopsies performed in the community setting lead to increased rates of postoperative wound complications in patients who underwent neoadjuvant radiation therapy followed by surgical resection. Median follow-up in this cohort was 3.5 years.
The overall wound complication rate within 6 months of resection was 25%. Of patients with postoperative wound complications, 1 (4.3%) had a grade 1 complication, 0 (0%) had a grade 2 complication, 12 (52.2%) had a grade 3 complication, and 10 (43.5%) had a grade 4 complication, according to CTCAE, version 4.0.
Of the percutaneous biopsies performed, 68 were done at the authors' tertiary sarcoma center and 24 were performed in the community setting. Postoperative wound complications occurred in 12 (18%) of the percutaneous biopsies performed at the tertiary hospital vs 10 (46%) performed at the community institution (P=.01). In addition to the higher rate of wound complications, the incidence of grade 4 wound complications was higher in the community setting, with a 14% rate of CTCAE grade 4 wound complications in biopsies performed at a tertiary sarcoma center vs a 73% rate of CTCAE grade 4 wound complications in biopsies performed in the community setting (P=.005).
The rate of wound complications in patients undergoing percutaneous biopsy by a nonmusculoskeletal trained radiologist or surgeon was 50% vs 18% when biopsy was performed by a musculoskeletal trained radiologist (P=.01). The rate of wound complications in patients who received preoperative radiation therapy at a sarcoma center was lower than that in patients who received radiation therapy at a community hospital (25% vs 34%, P=.36).
The secondary objective of the study was to determine which clinical and pathologic factors correlated with postoperative wound complications. In this study, predictors of postoperative wound complications on univariate analysis included lower-extremity soft tissue sarcoma (P=.02), sacrifice of a major vein (P=.01), and biopsy performed in the community setting (P=.01). Multivariate analysis showed that lower-extremity soft tissue sarcomas (P=.03; 95% confidence interval, 0.005-0.740; odds ratio, 0.06) led to a lower rate of wound complications and that biopsies performed in the community setting (P=.01; 95% confidence interval, 1.58-21.15; odds ratio, 5.79) led to increased wound complications postoperatively. None of the other variables assessed proved to be a significant predictor of wound complications ( Table 4) .
discussion
Percutaneous biopsy is a reliable tool for identifying soft tissue sarcomas compared with traditional open biopsy. [18] [19] [20] [21] [22] Advantages of percutaneous core biopsy include decreased cost and lower complications compared with open biopsy. 23, 24 In addition, percutaneous biopsy for sarcoma significantly minimizes the amount of tissue that must be excised during resection of the biopsy tract during wide resection. This can have a dramatic effect on the ability to primarily close a wound and avoid wound healing complications. 25 Although the rate of complications of percutaneous biopsy may be relatively low, it is unknown whether biopsies performed for the diagnosis of soft tissue sarcomas in the community setting lead to higher rates of wound complications postoperatively. To the authors' knowledge, no studies have investigated the relationship between treatment outcomes and the setting of percutaneous biopsies.
In the current study, a striking number of patients who had percutaneous biopsies at a community hospital (46%) had postoperative wound complications compared with those who underwent percutaneous biopsies at a sarcoma center (18%, P=.01). Additionally, the incidence of grade 4 toxicity was higher when percutaneous biopsy was performed in the community setting (73%) than when it was performed at a sarcoma center (14%, P=.005).
Increased wound complication rates were also seen when patients underwent percutaneous biopsies performed by nonmusculoskeletal trained physicians compared with those performed by musculoskeletal specialists (50% vs 18%, P=.01) and at nonacademic centers compared with academic centers (34% vs 25%, P=.36).
Mankin et al 7, 8 reported increased rates of complications when biopsies were performed outside of sarcoma centers. Patients who had biopsies performed by members of the Musculoskeletal Tumor Society at the treatment facility reported a lower frequency of skin and soft tissue complications. [7] [8] The current study supported these conclusions and showed that the postoperative course can be affected by the setting where the biopsy is performed.
The current study also showed that lower-extremity soft tissue sarcomas have a higher risk of postoperative wound complications. This finding was consistently identified in a number of previous reports. 12, 13, [25] [26] [27] Of the lower-extremity subsites, the proximal lower extremity has been associated with problems with wound healing. 12, 25 Two hundred nine patients with soft tissue sarcomas were retrospectively reviewed at the University of Florida. Of these, 130 had proximal lower-extremity tumors. In this study, lower-extremity wound complications occurred in 41 of 155 lower-extremity lesions (26%). 26 The Canadian National Cancer Institute 12 reported a randomized trial comparing preoperative and postoperative radiation alone for extremity soft tissue sarcomas. Most wound complications in patients treated with preoperative radiation therapy occurred in the upper leg, including the knee.
The cause of increased susceptibility to postoperative wound complications in percutaneous biopsies performed in the community setting may be difficult to elucidate. Perhaps biopsies performed by nonmusculoskeletal trained radiologists The biopsy method may also account for the increased risk of postoperative wound complications in percutaneous biopsies performed in the community setting. At the treating institution, coaxial biopsy needles are used for pathologic confirmation of disease. Coaxial needles provide a well-defined path that allows multiple samples to be obtained through 1 percutaneous puncture. This method potentially protects the surrounding tissue from seeding and repetitive trauma. However, some institutions may use a scatter approach for biopsy of potential soft tissue sarcomas that results in multiple wounds and placement of instrumentation through these wounds. This approach could increase the risk of wound complications. These differences in biopsy techniques may increase the risk of bleeding or hemorrhage within and around the tumor, compromise tissue perfusion, and increase the likelihood of wound complications.
Finally, preoperative radiation therapy increases the risk of postoperative wound complications. However, the setting where patients undergo radiation therapy is also important in the development of wound complications. In this study, patients who received radiation therapy at a nontertiary center had a higher rate of wound complications (34%) than those who were treated at the sarcoma center (25%, P=.36). Reasons could include more conformal radiation therapy techniques, availability of advanced technology and treatment methods, and improved quality assurance. Unfortunately, none of these variables could be assessed retrospectively.
Limitations
This study had several limitations. First, delineating the exact method of biopsy in the community setting was challenging because the method was not consistently documented. Therefore, comparison of techniques was difficult. The sample size was also small, and the population of soft tissue sarcomas was relatively inhomogeneous, particularly with regard to histology. Finally, as with all retrospective studies, there were corresponding inherent biases that could not be avoided.
conclusion
Patients who had lower-extremity soft tissue sarcomas and underwent biopsy performed at a community hospital or by a nonmusculoskeletal trained radiologist or surgeon had an increased risk of postoperative wound complications. Management of soft tissue sarcomas at an institution with experienced sarcoma specialists may decrease the incidence of postoperative wound complications. Previous studies established that soft tissue sarcomas should be treated at a tertiary sarcoma center. This study suggests that optimal care of patients with soft tissue sarcomas can be obtained with referral to a sarcoma center before biopsy, regardless of biopsy type.
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